A prospective study on hospitalization due to drug-related problems in a tertiary care hospital

Konuru, Venkateswarlu; Naveena, B.; Reddy, E. Sneha; Vivek, Bandela Charles; Shravani, G

doi:10.4103/jpbs.jpbs_35_18

Cited by 4 publications

(3 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, less than half of pharmacists (44%) had conducted a dermatology medication use review (MUR) and had modest confidence in conducting one 42 . Occasionally, the pharmacist was responsible for a drug‐related problem (4.4%) but this was at a much lower rate than the patient (47.16%) or caregiver (17%) 31 …”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

The Pharmacist's role in dermatology: Patient medication adherence

Pathak,

Chandy,

Shah

et al. 2023

The Journal of Dermatology

View full text Add to dashboard Cite

Medication non‐adherence is currently estimated to have caused at least 100 000 preventable deaths and over $100 billion in preventable medical costs. Adherence is particularly poor in dermatological conditions, with more than 50% of patients discontinuing topical treatments within the first year. Pharmacists are among the most accessible health‐care professionals with the potential to greatly impact medication non‐adherence through patient education, medication therapy management, and improved access to care. This review aimed to determine how pharmacists have improved medication adherence in dermatology and discuss strategies for further involvement. An extensive medical literature search using the PubMed database was conducted to evaluate clinical studies, published in the last 20 years, that have evaluated the pharmacist's role and impact on adherence of to dermatological products. PubMed search terms include: “pharmacists' role in dermatologic medication adherence”, “pharmacist‐led interventions in dermatology”, “pharmacist medication adherence dermatology” and “pharmacist intervention dermatology”. A total of 18 relevant studies were identified. Pharmacists improved dermatological medication adherence by increasing access to medications, providing medication counseling programs, and performing treatment monitoring services. However, corticophobia may contribute to pharmacists' hesitancy in making corticosteroid over‐the‐counter recommendations. Pharmacists are accessible health‐care providers with the potential to improve dermatological medication adherence. Future advanced training in dermatology medications may refine pharmacists’ knowledge of dermatological products.

show abstract

Section: Resultsmentioning

confidence: 99%

“…42 Occasionally, the pharmacist was responsible for a drug-related problem (4.4%) but this was at a much lower rate than the patient (47.16%) or caregiver (17%). 31 Pharmacists may play a vital role in treatment monitoring and medication adherence for systemic medication treatments.…”

Section: Re Sultsmentioning

confidence: 99%

The Pharmacist's role in dermatology: Patient medication adherence

Pathak,

Chandy,

Shah

et al. 2023

The Journal of Dermatology

View full text Add to dashboard Cite

show abstract

“…This increased number of DRPs can be explained by comorbidities and chronic medications. Increased numbers of DRPs may lead to prolonged hospital stay, ineffective drug treatment, and increased morbidity or even mortality 16 26. Involvement of clinical pharmacists in the healthcare team has proven effective in identifying and resolving DRPs during the entire hospital stay 25 27.…”

Section: Discussionmentioning

confidence: 99%

Drug-related problems at the heart of cardiac surgery

et al. 2023

View full text Add to dashboard Cite

ObjectivesOptimal perioperative success in cardiac surgery requires precise management of drug treatment. This study aimed to determine the prevalence, types and associated factors of drug-related problems (DRPs) during the entire hospital stay.MethodsA prospective observational study was conducted at the department of cardiovascular surgery in a university hospital between November 2019 and March 2020. Patients with planned elective cardiac surgery, aged ≥18 years, were included. A clinical pharmacist collaboratively reviewed medications on a daily basis and identified DRPs.ResultsA total of 100 patients (60 male) were included; median (range) age was 62 (19–86) years, and median (IQR) length of stay in hospital was 15 (9) days. A total of 275 DRPs were identified (median (IQR) 3 (2–4)). The number of patients who had at least one DRP was 47 preoperatively, 55 in the postoperative intensive care unit, 100 in the postoperative ward, and 16 at discharge. In order to reduce bias because of the small sample size, Firth’s logistic regression analysis was conducted. Statistically significant variables according to univariate analysis were included into a logistic regression model. Therefore the length of hospital stay (OR 1.14, 95% CI 1.03 to 1.26, p=0.008), living arrangements (living alone) (OR 4.24, 95% CI 1.41 to 12.73, p=0.009), number of medications at admission (OR 1.32, 95% CI 1.09 to 1.59, p=0.002), and having coronary artery bypass graft surgery (OR 2.87, 95% CI 1.07 to 7.70, p=0.03) were associated with an increased risk for DRPs in the final model.ConclusionHospital stay carries an increased risk for DRPs, especially at the postoperative stage. Modifiable risk factors for DRPs can be managed by required interventions performed by a multidisciplinary healthcare team.

show abstract

Pediatric Drug-Related Problems in an Indian Tertiary Care Hospital

Jahan

Kumari

Hamshika

et al. 2021

ADCTRA

View full text Add to dashboard Cite

Background: Improper drug usages expose patients to drug-related problems (DRPs) and can be the cause of patient morbidity and even mortality, especially frequent in hospitalized patients and pediatric groups. Objective: The objective of the present study was to identify and assess the drug-related problems in the pediatric department of tertiary care hospitals. Methods: The cross-sectional, observational study was carried out for six months included pediatric in-patients of age ≤15 years of either gender in pediatric units of tertiary care hospitals of India. The enrolled pediatric patients were observed for any drug-related problem that were further recorded and classified using the DRP registration format taken from Cipolle et al. The assessment of therapy was done by using positional statements from standard organizations and guidelines. Main outcome measure: Incidences of drug-related problems and their assessment and root cause analysis. Results: A total of 970 DRPs were identified in 296 patients, with an overall incidence of 49.3%. The incidence of DRPs was maximum in the age group of 2-12 years of children (51.2%). Patients who took six or more drugs were around eight (OR:8.41 , 95% CI: 5.22 to 13.55) times more likely to have DRPs compared to those patients who took less than six drugs. The incidences of DRPs were more in patients who were hospitalized for ≥ 7 days. Conclusion: The present study revealed significantly higher incidences of DRPs in hospitalized pediatric patients necessitating the involvement of clinical pharmacists in the pediatric department of tertiary care hospitals.

show abstract

A prospective study on hospitalization due to drug-related problems in a tertiary care hospital

Cited by 4 publications

References 8 publications

The Pharmacist's role in dermatology: Patient medication adherence

The Pharmacist's role in dermatology: Patient medication adherence

Drug-related problems at the heart of cardiac surgery

Pediatric Drug-Related Problems in an Indian Tertiary Care Hospital

Contact Info

Product

Resources

About